What is the appropriate management of an active gastrointestinal bleed?

Management of Active Gastrointestinal Bleeding

For active upper GI bleeding, perform endoscopy within 24 hours after initiating resuscitation with IV fluids and restrictive transfusion (hemoglobin <7 g/dL), start high-dose IV PPI therapy, and provide endoscopic hemostatic therapy for high-risk stigmata (active bleeding or visible vessel). 1

Initial Resuscitation and Risk Stratification

Start with immediate hemodynamic assessment and resuscitation:

• Transfuse red blood cells at hemoglobin threshold of 70-80 g/L (restrictive strategy improves outcomes) 2, 3
• Administer IV fluids as needed for hemodynamic stabilization
• Use validated risk stratification scores to identify low-risk patients who may be managed as outpatients 1, 3

Key clinical features indicating high risk: hemodynamic instability, advanced age, significant comorbidities, ongoing bleeding, and abnormal laboratory values 4, 3

Pre-Endoscopic Pharmacologic Management

For Suspected Peptic Ulcer Disease:

• Start IV PPI therapy (bolus followed by continuous infusion) - this may downstage lesions and decrease need for endoscopic intervention, though it should not delay endoscopy 1, 3
• Consider erythromycin as a prokinetic agent to improve visualization 3

For Suspected Variceal Bleeding (cirrhosis/portal hypertension):

• Administer antibiotics immediately 2, 4, 3
• Start vasoactive drugs (somatostatin analogues or octreotide) 2, 4, 3
• Perform endoscopy within 12 hours (earlier than non-variceal bleeding) 2

Important caveat: H2-receptor antagonists are NOT recommended and provide no benefit 1

Endoscopic Management Timing and Approach

Perform endoscopy within 24 hours of presentation for most patients with upper GI bleeding 1, 4, 3. Earlier endoscopy (within 12 hours) should be considered for:

• Hemodynamically unstable patients after resuscitation
• Suspected variceal bleeding 2

Endoscopic Therapy Based on Findings:

High-risk stigmata requiring intervention:

• Active bleeding (spurting or oozing)
• Non-bleeding visible vessel

Recommended endoscopic therapies for peptic ulcers with high-risk stigmata:

• Thermocoagulation or sclerosant injection (strong recommendation) 1
• Through-the-scope clips (conditional recommendation) 1
• Never use epinephrine injection alone - it provides suboptimal efficacy and must be combined with another method 1

Low-risk stigmata NOT requiring intervention:

• Clean-based ulcer
• Flat pigmented spot 1

Adherent clots: Attempt targeted irrigation to dislodge; if underlying high-risk lesion is revealed, treat accordingly. The role of therapy for adherent clots is controversial - intensive PPI therapy alone may be sufficient 1

Special Considerations for Non-Peptic Ulcer Bleeding

The 2025 Canadian guidelines 5 provide specific recommendations for increasingly common causes:

Malignant tumor bleeding:

• Use topical hemostatic agents over conventional therapy
• Administer oncologic therapy after endoscopic intervention

Mallory-Weiss tears with active bleeding:

• Use endoscopic band ligation or clips over epinephrine alone
• For non-bleeding tears (even with visible vessels), do NOT perform endoscopic therapy 5

Dieulafoy's lesions:

• Use mechanical modalities (band ligation or clips), contact thermocoagulation, or sclerosants
• Avoid epinephrine injection alone 5

Gastric antral vascular ectasia (GAVE):

• Prefer endoscopic band ligation over argon plasma coagulation 5

Post-Endoscopic Management

For patients who received endoscopic therapy for high-risk stigmata:

• Continue high-dose IV PPI (bolus followed by continuous infusion for 72 hours) 1
• Transition to twice-daily oral PPI for 14 days, then once daily 1
• Hospitalize for at least 72 hours after endoscopic hemostasis 1

For low-risk lesions (clean base, flat spots):

• Standard once-daily PPI dosing is sufficient
• Early feeding within 24 hours is appropriate 1
• Prompt discharge may be considered 1

Management of Rebleeding

If rebleeding occurs:

• Attempt second endoscopic therapy (generally recommended) 1
• If second endoscopy fails or bleeding persists: consider interventional radiology (embolization) or surgery 1, 3
• Routine second-look endoscopy is NOT recommended 1

Anticoagulation Management

Do not delay endoscopy in patients on anticoagulants (warfarin or DOACs) 1. The decision to reverse anticoagulation depends on:

• Severity of bleeding (life-threatening vs. controlled)
• Indication for anticoagulation (thrombotic risk)
• Type of anticoagulant

For patients on aspirin with established cardiovascular disease:

• Resume aspirin early after bleeding ceases (within 7 days, ideally 1-3 days) with PPI 3, 6
• Outcomes are better with early reintroduction 3

Etiologic Management

Test all patients for H. pylori and provide eradication therapy if positive, with confirmation of cure 1. Negative tests in acute settings should be repeated 1.

For NSAID-related ulcers:

• Stop NSAIDs if possible
• If NSAIDs must be resumed: use low-dose COX-2 selective NSAID plus PPI 6

For idiopathic ulcers: Long-term anti-ulcer therapy is indicated 6

Lower GI Bleeding Considerations

For lower GI bleeding:

• CT angiography is useful for locating active bleeding 2, 7
• Colonoscopy remains the gold standard but does not need to be urgent (within 24 hours) for most patients 2, 7
• Non-urgent colonoscopy has similar outcomes to urgent colonoscopy for most lower GI bleeds 7